Literature DB >> 11502627

Treatment experience of multidrug-resistant tuberculosis in Florida, 1994-1997.

M Narita1, P Alonso, M Lauzardo, E S Hollender, A E Pitchenik, D Ashkin.   

Abstract

OBJECTIVE: To study the clinical characteristics and results of patients with diagnoses of multidrug-resistant tuberculosis (MDR-TB) in the state of Florida.
METHODS: Retrospective chart review of all patients (n = 81) with diagnoses of MDR-TB in Florida between January 1, 1994, and July 31, 1997.
RESULTS: The average number of resistant drugs was 4.8 (range, 2 to 11). Of 81 patients, 46 patients (57%) completed adequate therapy, 26 patients (32%) died, and 9 patients (11%) never completed a satisfactory course of treatment. Patients who received at least part of their therapy at A. G. Holley State Hospital, a specialized tuberculosis (TB) treatment center, had significantly higher treatment completion rates (79%) than those treated as outpatients alone (48% treatment completion rate, p < 0.001), even after the exclusion of patients who were acutely ill and died within 2 months of diagnosis.
CONCLUSION: In Florida, a specialized TB care program for MDR-TB, including at least partial inpatient therapy, yielded higher treatment completion rates compared to outpatient treatment alone.

Entities:  

Mesh:

Year:  2001        PMID: 11502627     DOI: 10.1378/chest.120.2.343

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  13 in total

1.  Outcomes of multidrug-resistant tuberculosis among binational cases in El Paso, Texas.

Authors:  Gustavo Ferrer; Carlos Acuna-Villaorduna; Miguel Escobedo; Esteban Vlasich; Manuel Rivera
Journal:  Am J Trop Med Hyg       Date:  2010-11       Impact factor: 2.345

2.  The California Multidrug-Resistant Tuberculosis Consult Service: a partnership of state and local programs.

Authors:  N S Shah; J Westenhouse; P Lowenthal; G Schecter; L True; S Mase; P M Barry; J Flood
Journal:  Public Health Action       Date:  2018-03-21

3.  A close-up on the epidemiology and transmission of multidrug-resistant tuberculosis in Poland.

Authors:  T Jagielski; A Brzostek; A van Belkum; J Dziadek; E Augustynowicz-Kopeć; Z Zwolska
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-07-20       Impact factor: 3.267

4.  Resistance to fluoroquinolones and second-line injectable drugs: impact on multidrug-resistant TB outcomes.

Authors:  Dennis Falzon; Neel Gandhi; Giovanni B Migliori; Giovanni Sotgiu; Helen S Cox; Timothy H Holtz; Maria-Graciela Hollm-Delgado; Salmaan Keshavjee; Kathryn DeRiemer; Rosella Centis; Lia D'Ambrosio; Christoph G Lange; Melissa Bauer; Dick Menzies
Journal:  Eur Respir J       Date:  2012-10-25       Impact factor: 16.671

Review 5.  A systematic review of the effectiveness of hospital- and ambulatory-based management of multidrug-resistant tuberculosis.

Authors:  Amal Bassili; Christopher Fitzpatrick; Ejaz Qadeer; Razia Fatima; Katherine Floyd; Ernesto Jaramillo
Journal:  Am J Trop Med Hyg       Date:  2013-08       Impact factor: 2.345

6.  Feasibility and cost-effectiveness of treating multidrug-resistant tuberculosis: a cohort study in the Philippines.

Authors:  Thelma E Tupasi; Rajesh Gupta; Ma Imelda D Quelapio; Ruth B Orillaza; Nona Rachel Mira; Nellie V Mangubat; Virgil Belen; Nida Arnisto; Lualhati Macalintal; Michael Arabit; Jaime Y Lagahid; Marcos Espinal; Katherine Floyd
Journal:  PLoS Med       Date:  2006-09       Impact factor: 11.069

Review 7.  Treatment outcomes of multidrug-resistant tuberculosis: a systematic review and meta-analysis.

Authors:  James C Johnston; Neal C Shahidi; Mohsen Sadatsafavi; J Mark Fitzgerald
Journal:  PLoS One       Date:  2009-09-09       Impact factor: 3.240

8.  Treatment outcomes of patients with multidrug-resistant and extensively drug-resistant tuberculosis according to drug susceptibility testing to first- and second-line drugs: an individual patient data meta-analysis.

Authors:  Mayara L Bastos; Hamidah Hussain; Karin Weyer; Lourdes Garcia-Garcia; Vaira Leimane; Chi Chiu Leung; Masahiro Narita; Jose M Penã; Alfredo Ponce-de-Leon; Kwonjune J Seung; Karen Shean; José Sifuentes-Osornio; Martie Van der Walt; Tjip S Van der Werf; Wing Wai Yew; Dick Menzies
Journal:  Clin Infect Dis       Date:  2014-08-05       Impact factor: 9.079

9.  Multidrug resistant pulmonary tuberculosis treatment regimens and patient outcomes: an individual patient data meta-analysis of 9,153 patients.

Authors:  Shama D Ahuja; David Ashkin; Monika Avendano; Rita Banerjee; Melissa Bauer; Jamie N Bayona; Mercedes C Becerra; Andrea Benedetti; Marcos Burgos; Rosella Centis; Eward D Chan; Chen-Yuan Chiang; Helen Cox; Lia D'Ambrosio; Kathy DeRiemer; Nguyen Huy Dung; Donald Enarson; Dennis Falzon; Katherine Flanagan; Jennifer Flood; Maria L Garcia-Garcia; Neel Gandhi; Reuben M Granich; Maria G Hollm-Delgado; Timothy H Holtz; Michael D Iseman; Leah G Jarlsberg; Salmaan Keshavjee; Hye-Ryoun Kim; Won-Jung Koh; Joey Lancaster; Christophe Lange; Wiel C M de Lange; Vaira Leimane; Chi Chiu Leung; Jiehui Li; Dick Menzies; Giovanni B Migliori; Sergey P Mishustin; Carole D Mitnick; Masa Narita; Philly O'Riordan; Madhukar Pai; Domingo Palmero; Seung-kyu Park; Geoffrey Pasvol; Jose Peña; Carlos Pérez-Guzmán; Maria I D Quelapio; Alfredo Ponce-de-Leon; Vija Riekstina; Jerome Robert; Sarah Royce; H Simon Schaaf; Kwonjune J Seung; Lena Shah; Tae Sun Shim; Sonya S Shin; Yuji Shiraishi; José Sifuentes-Osornio; Giovanni Sotgiu; Matthew J Strand; Payam Tabarsi; Thelma E Tupasi; Robert van Altena; Martie Van der Walt; Tjip S Van der Werf; Mario H Vargas; Pirett Viiklepp; Janice Westenhouse; Wing Wai Yew; Jae-Joon Yim
Journal:  PLoS Med       Date:  2012-08-28       Impact factor: 11.069

10.  Randomized trials to optimize treatment of multidrug-resistant tuberculosis.

Authors:  Carole D Mitnick; Kenneth G Castro; Mark Harrington; Leonard V Sacks; William Burman
Journal:  PLoS Med       Date:  2007-11-06       Impact factor: 11.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.